![Pharmacokinetics and pharmacodynamics of peginterferon beta‐1a in patients with relapsing‐remitting multiple sclerosis in the randomized ADVANCE study - Hu - 2015 - British Journal of Clinical Pharmacology - Wiley Online Library Pharmacokinetics and pharmacodynamics of peginterferon beta‐1a in patients with relapsing‐remitting multiple sclerosis in the randomized ADVANCE study - Hu - 2015 - British Journal of Clinical Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/d865b2b8-fbbc-45bd-9f7c-e4b9d11bf8fb/bcp12521-fig-0003-m.jpg)
Pharmacokinetics and pharmacodynamics of peginterferon beta‐1a in patients with relapsing‐remitting multiple sclerosis in the randomized ADVANCE study - Hu - 2015 - British Journal of Clinical Pharmacology - Wiley Online Library
![Proteomics and Informatics for Understanding Phases and Identifying Biomarkers in COVID-19 Disease | Journal of Proteome Research Proteomics and Informatics for Understanding Phases and Identifying Biomarkers in COVID-19 Disease | Journal of Proteome Research](https://pubs.acs.org/cms/10.1021/acs.jproteome.0c00326/asset/images/medium/pr0c00326_0003.gif)
Proteomics and Informatics for Understanding Phases and Identifying Biomarkers in COVID-19 Disease | Journal of Proteome Research
![Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development - H Hegen, A Millonig, A Bertolotto, M Comabella, G Giovanonni, M Guger, M Hoelzl, Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development - H Hegen, A Millonig, A Bertolotto, M Comabella, G Giovanonni, M Guger, M Hoelzl,](https://journals.sagepub.com/cms/10.1177/1352458513503597/asset/images/large/10.1177_1352458513503597-fig5.jpeg)
Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development - H Hegen, A Millonig, A Bertolotto, M Comabella, G Giovanonni, M Guger, M Hoelzl,
Contribution of Nitrated Phenols to Wood Burning Brown Carbon Light Absorption in Detling, United Kingdom during Winter Time | Environmental Science & Technology
![Frontiers | Antiretroviral Treatment-Induced Decrease in Immune Activation Contributes to Reduced Susceptibility to Tuberculosis in HIV-1/Mtb Co-infected Persons Frontiers | Antiretroviral Treatment-Induced Decrease in Immune Activation Contributes to Reduced Susceptibility to Tuberculosis in HIV-1/Mtb Co-infected Persons](https://www.frontiersin.org/files/MyHome%20Article%20Library/645446/645446_Thumb_400.jpg)
Frontiers | Antiretroviral Treatment-Induced Decrease in Immune Activation Contributes to Reduced Susceptibility to Tuberculosis in HIV-1/Mtb Co-infected Persons
![Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development - H Hegen, A Millonig, A Bertolotto, M Comabella, G Giovanonni, M Guger, M Hoelzl, Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development - H Hegen, A Millonig, A Bertolotto, M Comabella, G Giovanonni, M Guger, M Hoelzl,](https://journals.sagepub.com/cms/10.1177/1352458513503597/asset/images/large/10.1177_1352458513503597-fig2.jpeg)
Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development - H Hegen, A Millonig, A Bertolotto, M Comabella, G Giovanonni, M Guger, M Hoelzl,
![Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study - The Lancet Gastroenterology & Hepatology Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/attachment/2eaf2989-ed0d-4aa6-8ea5-d0645cd0163b/gr1_lrg.jpg)
Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study - The Lancet Gastroenterology & Hepatology
![Proteomics and Informatics for Understanding Phases and Identifying Biomarkers in COVID-19 Disease | Journal of Proteome Research Proteomics and Informatics for Understanding Phases and Identifying Biomarkers in COVID-19 Disease | Journal of Proteome Research](https://pubs.acs.org/cms/10.1021/acs.jproteome.0c00326/asset/images/medium/pr0c00326_0001.gif)
Proteomics and Informatics for Understanding Phases and Identifying Biomarkers in COVID-19 Disease | Journal of Proteome Research
![Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial | Nature Microbiology Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial | Nature Microbiology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41564-022-01262-1/MediaObjects/41564_2022_1262_Fig1_HTML.png)
Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial | Nature Microbiology
![Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development - H Hegen, A Millonig, A Bertolotto, M Comabella, G Giovanonni, M Guger, M Hoelzl, Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development - H Hegen, A Millonig, A Bertolotto, M Comabella, G Giovanonni, M Guger, M Hoelzl,](https://journals.sagepub.com/cms/10.1177/1352458513503597/asset/images/large/10.1177_1352458513503597-fig1.jpeg)
Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development - H Hegen, A Millonig, A Bertolotto, M Comabella, G Giovanonni, M Guger, M Hoelzl,
![Prevalence of neutralising antibodies to interferon-beta and clinical response in Chinese patients with relapsing multiple sclerosis - Alexander Y Lau, WK Ip, Cheryl Au, KK Lau, Winnie Wong, KK Yip, Jonas Yeung, Prevalence of neutralising antibodies to interferon-beta and clinical response in Chinese patients with relapsing multiple sclerosis - Alexander Y Lau, WK Ip, Cheryl Au, KK Lau, Winnie Wong, KK Yip, Jonas Yeung,](https://journals.sagepub.com/cms/10.1177/2055217317733485/asset/images/large/10.1177_2055217317733485-fig2.jpeg)
Prevalence of neutralising antibodies to interferon-beta and clinical response in Chinese patients with relapsing multiple sclerosis - Alexander Y Lau, WK Ip, Cheryl Au, KK Lau, Winnie Wong, KK Yip, Jonas Yeung,
![Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial | Nature Communications Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-35768-3/MediaObjects/41467_2022_35768_Fig1_HTML.png)